history – Page 2 – HCV Guidance

Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma–its relationship to alcohol drinking and the age of transfusion

May 3, 2017
Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010

May 3, 2017
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

May 3, 2017
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection

May 3, 2017
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

May 3, 2017
Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy

May 3, 2017
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis

May 3, 2017
HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study

May 3, 2017
The liver biopsy in chronic hepatitis C: a view from the other side of the microscope

May 3, 2017
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users

May 3, 2017